Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 18Endometrial Neoplasms 4Prostatic Neoplasms 3Sarcoma 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Neuroectodermal Tumors, Primitive, Peripheral 2Esophageal Neoplasms 2Endometrial Clear Cell Adenocarcinoma 2Vaginal Neoplasms 1Uveitis 1Uveal Melanoma 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Radiation Injuries 1Obesity 1Neurotoxicity Syndromes 1Neoplasms, Unknown Primary 1Malignant mesenchymal tumor 1Lung Neoplasms 1Locally Advanced Cervical Cancer 1Locally Advanced Cervical Adenocarcinoma 1Liver Neoplasms 1Liposarcoma 1Hyperthermia 1Hemangiosarcoma 1Hemangiopericytoma, Malignant 1Head and Neck Neoplasms 1Fibrosarcoma 1Fatigue 1Esophageal Squamous Cell Carcinoma 1

Interventions

pembrolizumab 1X-Rays 1Taxes 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Radiation 1Platinum 1Paclitaxel 1Magnetic Resonance Spectroscopy 1Congresses as Topic 1Cisplatin 1Carboplatin 1Brachytherapy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Locally Advanced Cervical Adenocarcinoma × Brachytherapy × Clear all
NCT07061977 2026-06-05

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

National Cancer Institute (NCI)

Phase 3 Recruiting
336 enrolled
Gynecologic

Locally Advanced Cervical Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡